The nerve to expect more. The nerve to reimagine your patients' potential.
Empower your patients with drug-resistant epilepsy to live fuller lives and achieve their full potential.
VNS Therapy™ is a neuromodulation treatment designed for people with drug-resistant epilepsy 4 years of age and older with partial onset seizures. It can safely lead to fewer and shorter seizures and better recovery after seizures.
Resources & Support
Discover the resources you need to make the most of VNS Therapy, including product training, expert healthcare provider perspectives, practice support, and patient education
VNS Therapy™ for Pediatric Patients
Examine the efficacy, safety, and quality of life benefits VNS Therapy™ can offer your pediatric patients with drug-resistant epilepsy
VNS Therapy™ for Adult Patients
Explore the benefits VNS Therapy™ can offer your adult patients with drug-resistant epilepsy, including improvements in seizure control and quality of life
Improving long-term seizure control
- Fewer, shorter, less severe seizures
- Improved postictal recovery
Minimizing treatment-related side effects
Ensuring treatment adherence
Maximizing quality of life
VNS Therapy™ stimulates the vagus nerve, sending mild electrical pulses to the brain to help prevent seizures2
Uses an implantable generator and lead and can be programmed to fit the needs of each patient2
Unlike invasive brain surgeries, VNS Therapy™ involves a short outpatient procedure that usually takes 1 to 2 hours2
Treatment is delivered automatically, maximizing adherence for optimal seizure control2
Helps prevent seizures by delivering treatment at regular intervals all day, every day2
Helps stop or shorten a seizure by responding to a rapid increase in heart rate, a potential seizure biomarker2-4
*Only available in models 106, 1000, and 1000-D
Helps stop or shorten a seizure once it starts by passing the included VNS Therapy Magnet over the generator2
Responsive VNS Therapy in action
prescribed device for treating DRE5
Only DRE neurostimulation therapy indicated to treat children as young as 4 years old2
125,000+ patients treated, including 35,000 children5
References: 1. Boon P, Ryvlin P, Wheless JW, et al. European Neurological Review. 2015;10(2):171-175. 2. VNS Therapy System® Epilepsy Physician’s Manual (US), May 2020, LivaNova USA, Inc. Houston, TX. 3. Fisher RS, Afra P, Macken M, et al. Neuromodulation. 2016;19:188-195. 4. Hirsch M, Altenmüller DM, Schulze-Bonhage A. Epilepsia. 2015;56(10):1639-1647. 5. Data on file, LivaNova, Inc., Houston, TX.